Connect with us
Watch Jon Pilcher, CEO of Neuren Pharmaceuticals (ASX:NEU), speaking about Neuren’s area of drug focus and the latest updates on the Trofinetide development. 0:11 – Firstly,...
Watch Dr. Nina Webster, CEO and MD of Dimerix (ASX:DXB) and Jared Sim, Editor-in-Chief and Co-Founder of StockPal in this engaging Q&A with the following questions:...
In this part three of a four-part webinar recap, Darren Lui, President and Executive Director of Aptorum Group (NASDAQ/EURONEXT:APM) presented on the company’s latest announcements and updates,...
In this one of a four-part webinar recap, Mark Diamond, Managing Director & CEO of Antisense Therapeutics Limited (ASX:ANP) presented on the company’s latest announcements and...
StockPal is hosting its first Biotech & Healthcare webinar on 4 August for four ASX- and NASDAQ-listed health care companies. This webinar is co-organised with Rawson Lewis....
StockPal is hosting its first Biotech & Healthcare webinar for four ASX- and NASDAQ-listed health care companies. Each company is given 15 minutes to present via...
Watch Darren Lui, President and Executive Director of Aptorum Group (NASDAQ:APM) and Jared Sim, Editor-in-Chief and Co-Founder of StockPal in this engaging Q&A with the following...
Ian Huen is the Founder, CEO and Managing Director of Aptorum Group (NASDAQ:APM), a Hong Kong based pharmaceutical company currently in the preclinical stage, dedicated to...